Latest News and Press Releases
Want to stay updated on the latest news?
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Helen of Troy Stock or Options To Contact Him Directly At...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Wealthfront Stock or Options To Contact Him Directly At 877-247-4292...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Hub Group Stock or Options To Contact Him Directly At 877-247-4292 or...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Duolingo Stock or Options To Contact Him Directly At 877-247-4292 or...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Helen of Troy To Contact Him Directly To Discuss Their Options If...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Hub Group To Contact Him Directly To Discuss Their Options If you...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Helen of Troy To Contact Him Directly To Discuss Their Options If...
-
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyndryl Holdings
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Kyndryl Holdings To Contact Him Directly To Discuss Their Options If...
-
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating potential claims on behalf of victims of pump-and-dump schemes involving the following securities:...
-
National law firm Morris Kandinov is investigating AvidXchange Holdings, Inc., iRhythm Technologies, Inc., Hayward Holdings, Inc., and iTeos Therapeutics.